Kazuaki Uchiyama

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

Kazuomi Kario, Kenta Okada, Mitsutoshi Kato et al. · Circulation · 2019 · 240 citations

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy

Sunao Kojima, Kunihiko Matsui, Shinya Hiramitsu et al. · European Heart Journal · 2019 · 218 citations · Full text

Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　― The NOCTURNE Study ―

Kazuomi Kario, Naoko Tomitani, Hiroshi Kanegae et al. · Circulation Journal · 2017 · 66 citations · Full text

Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia

Sunao Kojima, Kunihiko Matsui, Hisao Ogawa et al. · Journal of Cardiology · 2016 · 43 citations

Hypertension, Renal Function, Hyperthermia +10

Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease

Masaaki Konishi, Sunao Kojima, Kazuaki Uchiyama et al. · International Journal of Cardiology · 2021 · 37 citations

Metabolic Syndrome, Hypertension, Hyperthermia +11